Down-Regulation of eIF4GII by miR-520c-3p Represses Diffuse Large B Cell Lymphoma Development
暂无分享,去创建一个
K. Mazan-Mamczarz | K. Becker | Zhenqiu Liu | R. Gartenhaus | E. Lehrmann | B. Dai | R. Shaknovich | Yongqing Zhang | X. Zhao | J. Steinhardt | M. Sadowska | R. Peroutka | A. Landon | Kimberly L. Berk | K. Mazan‐Mamczarz
[1] K. Mazan-Mamczarz,et al. Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL). , 2013, Leukemia research.
[2] I. Keklikoglou,et al. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways , 2012, Oncogene.
[3] M. Serrano. Dissecting the role of mTOR complexes in cellular senescence , 2012, Cell cycle.
[4] Christopher J. Cheng,et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.
[5] A. Bader,et al. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo , 2012, Leukemia.
[6] A. Dejean,et al. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells , 2012, Nature Cell Biology.
[7] Michael J. Wilson,et al. miR‐520c and miR‐373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF‐κB factor in human fibrosarcoma cells , 2012, Journal of cellular physiology.
[8] K. Naresh,et al. BCL3 rearrangement, amplification and expression in diffuse large B‐cell lymphoma , 2011, European journal of haematology.
[9] N. Shomron,et al. Cancer, Senescence, and Aging: Translation from Basic Research to Clinics , 2011, Journal of aging research.
[10] C. Stumpf,et al. The cancerous translation apparatus. , 2011, Current opinion in genetics & development.
[11] K. Mazan-Mamczarz,et al. Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma , 2011, Nature communications.
[12] J. Clohessy,et al. Pro-senescence therapy for cancer treatment , 2011, Nature Reviews Cancer.
[13] H. Rehrauer,et al. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. , 2011, Blood.
[14] J. Chi,et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival , 2011, Biology Direct.
[15] M. Gorospe,et al. ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes. , 2011, Blood.
[16] Ker-Chau Li,et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. , 2011, Cell host & microbe.
[17] A. Willis,et al. Translation deregulation in B-cell lymphomas. , 2010, Biochemical Society transactions.
[18] C. Croce,et al. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application. , 2010, Cancer genetics and cytogenetics.
[19] D. Pisano,et al. MicroRNA signatures in B-cell lymphomas , 2010, Blood Cancer Journal.
[20] David F Jarrard,et al. Therapy-induced senescence in cancer. , 2010, Journal of the National Cancer Institute.
[21] W. Filipowicz,et al. Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.
[22] C. Bellodi,et al. Deregulation of oncogene‐induced senescence and p53 translational control in X‐linked dyskeratosis congenita , 2010, The EMBO journal.
[23] Huiling Yang,et al. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma , 2010, Molecular Cancer.
[24] M. Narita,et al. Connecting autophagy to senescence in pathophysiology. , 2010, Current opinion in cell biology.
[25] R. Gartenhaus,et al. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. , 2010, Blood.
[26] Doron Betel,et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.
[27] Y. Natkunam,et al. Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma. , 2009, Cancer research.
[28] K. Basso,et al. Identification of the human mature B cell miRNome. , 2009, Immunity.
[29] J. Chi,et al. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma , 2008, Journal of cellular and molecular medicine.
[30] Robert Tibshirani,et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.
[31] K. Mazan-Mamczarz,et al. Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. , 2008, Cancer research.
[32] S. Lowe,et al. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. , 2008, The Journal of clinical investigation.
[33] J. Zavadil,et al. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy , 2008, The Journal of cell biology.
[34] Lin Zhang,et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.
[35] R. Aguiar,et al. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. , 2008, Cancer genetics and cytogenetics.
[36] S. Lowe,et al. Dissecting eIF4E action in tumorigenesis. , 2007, Genes & development.
[37] Tao Wang,et al. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. , 2007, The Journal of clinical investigation.
[38] A. Degterev,et al. Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G , 2007, Cell.
[39] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[40] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[41] V. Polunovsky,et al. The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways , 2006, RNA biology.
[42] P. Meltzer. Cancer genomics: Small RNAs with big impacts , 2005, Nature.
[43] N. Sonenberg,et al. Selective Modification of Eukaryotic Initiation Factor 4F (eIF4F) at the Onset of Cell Differentiation: Recruitment of eIF4GII and Long-Lasting Phosphorylation of eIF4E , 2004, Molecular and Cellular Biology.
[44] N. Sonenberg,et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.
[45] P. Pandolfi,et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.
[46] J. Graff,et al. eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.
[47] M. Clemens,et al. Targets and mechanisms for the regulation of translation in malignant transformation , 2004, Oncogene.
[48] J. Shay,et al. Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.
[49] S. Lowe,et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.
[50] W. Klapper,et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.
[51] F. Meric,et al. Translation initiation in cancer: a novel target for therapy. , 2002, Molecular cancer therapeutics.
[52] V. Ambros. microRNAs Tiny Regulators with Great Potential , 2001, Cell.
[53] Myriam Gorospe,et al. Loss of HuR Is Linked to Reduced Expression of Proliferative Genes during Replicative Senescence , 2001, Molecular and Cellular Biology.
[54] H. Iro,et al. Translation initiation factor eIF‐4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma , 2001, Cancer.
[55] B. Woda,et al. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. , 1999, The American journal of pathology.
[56] N. Sonenberg,et al. A newly identified N‐terminal amino acid sequence of human eIF4G binds poly(A)‐binding protein and functions in poly(A)‐dependent translation , 1998, The EMBO journal.
[57] N. Sonenberg,et al. A Novel Functional Human Eukaryotic Translation Initiation Factor 4G , 1998, Molecular and Cellular Biology.
[58] T. Fukuchi-Shimogori,et al. Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.
[59] A. Hagemeijer,et al. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. , 1997, Cancer genetics and cytogenetics.
[60] N. Sonenberg,et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.
[61] A. Gingras,et al. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.